Drug search by name

Yondelis and Cardiomyopathy

Result of checking the interaction of drug Yondelis and disease Cardiomyopathy for safety when used together.

Check result:

Yondelis <> Cardiomyopathy

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Cardiomyopathy including cardiac failure, congestive heart failure, ejection fraction decreased, diastolic dysfunction, or right ventricular dysfunction can occur with the use of trabectedin. Care should be taken when using this agent in patients with heart disease. Assess LVEF before initiation of therapy and at 2- to 3-month intervals thereafter. It is recommended to withhold therapy for LVEF below lower limit of normal and permanently discontinue treatment for symptomatic cardiomyopathy or persistent left ventricular dysfunction that does not recover to lower limit of normal within 3 weeks.

Yondelis

Generic Name: trabectedin

Brand Name: Yondelis

Synonyms: n.a.

What is Yondelis?